openPR Logo
Press release

Cancer/Tumor Profiling Market SWOT Analysis to 2027 Lead By - Illumina, Qiagen, NeoGenomics Laboratories, HTG Molecular Diagnostics, Genomic Health, Caris Life Sciences, Helomics, NanoString Technologies, Oxford Gene Technology, Ribomed Biotechnologies

03-27-2019 08:11 PM CET | Health & Medicine

Press release from: The Insight Partners

Cancer/Tumor Profiling Market SWOT Analysis to 2027 Lead By -

The Cancer/Tumor Profiling Market report aims to provide a 360-degree view of the market in terms of cutting-edge technology, key developments, drivers, restraints and future trends with impact analysis of these trends on the market for short-term, mid-term and long-term during the forecast period. Further, the report also covers key players profiling with detailed SWOT analysis, financial facts and key developments of products/service from the past three years.

Tumor profiling services use a variety of methods for the examination of patient's tumor. Some utilize next generation DNA sequencing or RNA sequencing, while others analyze protein expression. Multiple technologies are used to provide very specific information about the molecular and genetic makeup of the tumor. Tumor profiling companies utilize various methods to examine the biopsy sample, and return information about the genes altered in the cancer cells.

Get Sample Copy of this Report at @ http://bit.ly/2OBEuAN

Key Benefits-

* To provide detailed information regarding the major factors (drivers, restraints, opportunities, challenges, and trends) influencing the growth of the global Cancer/Tumor Profiling Market

* To forecast the size of the market segments with respect to four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (Latin America and the Middle East & Africa)

The "Global Cancer/Tumor Profiling Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a focus on the global market trend. The report aims to provide an overview of global cancer/tumor profiling market with detailed market segmentation by technology, cancer type, application, and geography. The global Cancer/Tumor Profiling market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Cancer/Tumor Profiling market players and offers key trends and opportunities in the market.

The List of Companies

1. Illumina, Inc.
2. QIAGEN
3. NeoGenomics Laboratories, Inc.
4. HTG Molecular Diagnostics, Inc.
5. Genomic Health
6. Caris Life Sciences
7. Helomics Corp.
8. NanoString Technologies, Inc.
9. Oxford Gene Technology
10. Ribomed Biotechnologies, Inc.

The cancer/tumor profiling market is expected to grow in the forecast period owing to key factors such as growing number of new cancer cases, rising utility of biomarkers in tumor profiling, and availability of funding for cancer research. The market is likely to experience the growth opportunities in the emerging nations and the technological advancements, increasing demand for point-of-care diagnostic tests are likely to develop innovative products.

The global cancer/tumor profiling market is segmented on the basis of technology, cancer type and application. Based on technology, the market is segmented as immunoassays, hybridization, sequencing techniques, mass spectrometry, and others. On the basis of cancer type, the cancer/tumor profiling market segmentation is classified as lung cancer, breast cancer, colorectal cancer, prostate cancer, melanoma cancer, and others. Based on the application the market is segmented as clinical application and research application.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global cancer/tumor profiling market based on technology, cancer type and application. It also provides market size and forecast till 2027 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America.

The cancer/tumor profiling market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

North America is expected to contribute to the largest share in the cancer/tumor profiling market in the forecast period due to presence of major players and rapid advances in technology, high prevalence of cancer and increased research in oncology to identify and discover innovative therapy for cancer treatment. Asia Pacific is anticipated to be the fastest growing region due to the increasing incidence of cancer, rising demand for better healthcare services in developing economies such as India and China, growing number of contract research organizations (CROs), and increasing focus of international players on emerging markets.

The report analyzes factors affecting cancer/tumor profiling market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the cancer/tumor profiling market in these regions.

Buy this Report at @ http://bit.ly/2FEd1v7

Reason to Buy

- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Cancer/Tumor Profiling Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Cancer/Tumor Profiling Market, thereby allowing players to develop effective long term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:

Call: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer/Tumor Profiling Market SWOT Analysis to 2027 Lead By - Illumina, Qiagen, NeoGenomics Laboratories, HTG Molecular Diagnostics, Genomic Health, Caris Life Sciences, Helomics, NanoString Technologies, Oxford Gene Technology, Ribomed Biotechnologies here

News-ID: 1675350 • Views: 298

More Releases from The Insight Partners

IoT Sensors Market Opportunities and Forecast Assessment 2020 - 2027
IoT Sensors??????? Market 2020-2027 Industry research report is an in-depth and detailed study on the present situation of the IoT Sensors??????? industry by focusing on the worldwide market. Additionally, this report presents a basic outlook, share, size, growth, dynamics, competitive analysis, manufacturers and global business strategy & statistics analysis. This report is segmented on basis of product type, end-user, application and geographical regions. About "IoT Sensors Market" Growth: The global IoT sensors
3D Printing Medical Devices Market Demand, Supply, Growth Factors, Latest Rising …
Worldwide 3D Printing Medical Devices Market Analysis to 2027 is a specialized and in-depth study of the 3D Printing Medical Devices Industry with a focus on the global market trend. The report aims to provide an overview of global 3D Printing Medical Devices Market with detailed market segmentation by product/application and geography. The global 3D Printing Medical Devices Market is expected to witness high growth during the forecast period. The
Artificial Intelligence In Fashion Market Research Report 2020 Global Analysis A …
Artificial Intelligence In Fashion??????? Market 2020-2027 Industry research report is an in-depth and detailed study on the present situation of the Artificial Intelligence In Fashion??????? industry by focusing on the worldwide market. Additionally, this report presents a basic outlook, share, size, growth, dynamics, competitive analysis, manufacturers and global business strategy & statistics analysis. This report is segmented on basis of product type, end-user, application and geographical regions. About "Artificial Intelligence In
Medical Robots Market Size,share, Demand, Growth, Opportunities and Analysis of …
According to a new market research study titled 'Medical Robots Market to 2025 - Global Analysis and Forecasts by Product, Application and End User, the global medical robots market was valued at US$ 5,740.8Mn in 2017 and is estimated to reach US$ 28,776.6Mn by 2025. The report highlights the trends prevalent in the global medical robots market and the factors driving the market along with the restraints that are impacting

All 5 Releases


More Releases for Tumor

Rising Prevalence of brain Tumor Couple with Geriatric Populations supporting gr …
Albany, NY, 26th February : Recent research and the current scenario as well as future market potential of "Brain Tumor Therapeutics: Global Markets to 2023" globally. ResearchMOZ.us has published a fresh report to its vast repository titled “Global Brain Tumor Therapeutics Market - Segmented by Type of Cancer and Therapeutics - Growth, Trends and Forecasts 2018-2026” to its offerings. The report provides comprehensive analysis of the global tumor therapeutics market in the
Global Tumor Ablation Devices Market - Insights
Increasing prevalence of various cancer globally rising the demand of treatment through ablation procedure due to its lesser/minimal side effect rates over other procedures intended to boost the tumor ablation devices market. According to the World Health Organization (WHO), cancer is one of the leading causes of morbidity and mortality across the world, with approximately 14 million new cases reported worldwide in 2012. Click To Continue Reading: https://www.coherentmarketinsights.com/market-insight/tumor-ablation-devices-market-1270 Tumor Ablation devices market
Global Tumor Ablation Devices Market - Insights
Rising prevalence of tumor cases is the major factor that contributes in the growth of the tumor ablation devices market. According the Central Brain Tumor Registry of the US (CBTRUS), 2015, there are over 138,000 people in the US living with primary brain and central nervous system malignant tumors. Various key players are involved in sustainable development of minimally invasive ablation devices for various types such as catheter ablation, cryoablators,
Tumor Ablation Market: Industry Evolution/Development
A recent study by Transparency Market Research (TMR) has detected that the competition in the global tumor ablation market is intense, in a fragmented scenario with the presence of a number of participants. That being said, there are plenty of growth opportunities too in the market for tumor ablation, which will continue to attract pharmaceutical companies and further intensify the competition. The TMR report projects the global tumor ablation market
Tumor Necrosis Factor Receptor
WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Tumor Necrosis Factor - Pipeline Review, H2 2017” Tumor Necrosis Factor Overview Tumor Necrosis Factor Receptor Superfamily Member 18 (Glucocorticoid Induced Tumor Necrosis Factor Receptor or Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) pipeline Target constitutes close to 14 molecules. Out of which approximately 14 molecules are developed
Personalised tumor vaccines keep cancer in check
Throughout the last decade, novel cancer therapeutics has seen tremendous developments, through targeting tumor cell-intrinsic pathways, as well as targeting tumor cell-extrinsic factors such as growth factors. Notable clinical success of checkpoint inhibitors as well as adoptively transferred genetically engineered T cells further demonstrates the critical role of T-cells in cancer control and rejection. However, many patients still do not respond to checkpoint inhibitor therapies. This creates the need for